ADC高效低毒，成为HER2阳性晚期乳腺癌患者的优选方案。人表皮生长因子受体2(HER2)在大约20-25%的乳腺癌中扩增或过表达，与乳腺癌细胞的增殖和侵袭能力密切相关[1]。其生物学行为表现为高复发、转移、耐药和预后不良[2]。常规治疗包括大分子单 ...

We're learning more about the craving that fuels self-defeating habits—and how new discoveries can help us kick the habit. Addiction hijacks the brain’s neural pathways. Scientists are ...